Overall Risk Summary
The opportunity is meaningful, but the path is narrow. Amprius must line up three things in sequence: reliable partner output, compliant domestic or allied supply for defense-linked demand, and repeat purchase orders that prove the chemistry edge survives procurement scrutiny. The business is less exposed to software commoditization than most AI-adjacent names, yet it is more exposed to supplier power, customer concentration, and valuation risk.